NCT07237503 2025-11-19
THE EFFECT OF CALISTHENIC EXERCISES ON FATIGUE AND EXERCISE ATTITUDES IN PATIENTS WITH LUNG CANCER
Hasan Kalyoncu University
Phase NA Active not recruiting
Clinical Trials
15 trialsNCT07042724 2025-06-29
STARLighT
Universita di Verona
Phase NA Recruiting
NCT05509751 2024-11-08
SOAR
University of Toronto
Phase NA Recruiting
NCT04131426 2023-08-15
Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia
University of Rochester
Phase 1 Completed
NCT05959265 2023-07-25
Effect of Exercise Therapy on Psychological State and Clinical Prognosis of Advanced Non-small Cell Lung Cancer
The First Affiliated Hospital of Guangzhou Medical University
Phase NA Unknown
NCT00717795 2023-06-07
Physical Activity Intervention for Lung Cancer Survivors
Memorial Sloan Kettering Cancer Center
Completed
NCT04667065 2023-05-23
PREPACHIR
Centre Hospitalier Intercommunal Creteil
Phase NA Completed
NCT05279521 2022-03-15
The Effect of Interventional Pulmonary Rehabilitation Exercise With Advanced Lung Cancer.
National Taiwan University Hospital
Phase NA Unknown
NCT04722393 2021-01-25
Lung Resection and Pulmonary Rehabilitation
Izmir Katip Celebi University
Phase NA Completed
NCT03162718 2019-03-05
A Feasibility Study of Unsupervised, Pre-operative Exercise Program for Patients Scheduled for Lung Cancer Surgery
Dartmouth-Hitchcock Medical Center
Phase NA Completed
NCT02585362 2019-01-11
Whey Protein Supplement in Combination With Physical Exercise and Nutrition Program
Kantonsspital Winterthur KSW
Phase NA Completed
NCT02755883 2018-02-07
Strides for Life I: Increasing Physical Activity in Stage 1 Lung Cancer Patients
Weill Medical College of Cornell University
Phase NA Completed
NCT01048762 2015-10-22
Multidisciplinary Rehabilitation After Cancer Pulmonis Operation
Aalborg University Hospital
Phase 2 Completed
NCT01540968 2015-06-26
Nutrition and Physical Exercise Study
Kantonsspital Winterthur KSW
Phase NA Completed
NCT00891761 2015-04-17
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
GlaxoSmithKline
Phase 3 Withdrawn